Abstract
Neurocognition is a critically important dimension of our daily functioning that is impacted negatively by a host of non-neurological, systemic diseases. In the field of behavioral medicine, neurocognitive testing is used to examine the impact of such diseases and their risk factors on multiple domains of function including attention; learning and memory; executive functions; visuospatial; psychomotor; and perceptual abilities; and language. In that regard, a host of behavioral, biomedical, psychosocial, and psychophysiological risk factors and a broad spectrum of systemic medical diseases confer vulnerability to (or in some instances resilience against) cognitive difficulties, subclinical cerebrovascular disease, and ultimately dementia or stroke. Neurocognitive assessment can also be used to help facilitate an understanding of medical decision making, treatment outcomes, quality of life, and functional status. For example, the executive functions may have a particularly important role in health behaviors and their change, management of chronic disease and chronic pain, treatment adherence, and other medical decision making. Neuropsychological assessment is highly relevant to the study and practice of behavioral medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Andersen, C. K., Wittrup-Jensen, K. U., Lolk, A., Andersen, K., and Kragh-Sørensen, P. (2004). Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes, 2, 1–7.
Armstrong, C., and Morrow, L. A. (in press) Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience. New York: Springer.
Bellia V, Pedone C, Catalano F, Zito A, Davì E et al (2007). Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest, 132, 1175–1182.
Berr, C., Balansard, B., Arnaud, J. et al (2000). Cognitive decline is associated with systemic oxidative stress: the EVA study. J Am Geriatr Soc, 48, 1285–1291.
Biessels, G. J., Deary, I. J., and Ryan, C. M. (2008). Cognition and diabetes: a lifespan perspective. Lancet Neurol,7, 184–190.
Blume, A. W., and Marlatt, G. A. (2009). The role of executive cognitive functions in changing substance use: what we know and what we need to know. Ann Behav Med, 37, 117–125.
Borson S, Scanlan J, Friedman S, Zuhr E, Fields J et al (2008). Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis, 3, 429–434.
Cohen, R. A., Poppas, A., Forman, D. E. et al (2009). Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol, 31, 96–110.
Colcombe, S. J., Kramer, A. F., Erickson, K. I., Scalf P, McAuley E et al (2004). Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sc, 101, 3316–3321.
Del Parigi, A., Panza, F., Capurso, C., and Solfrizzi, V. (2006). Nutritional factors, cognitive decline, and dementia. Brain Res Bull, 69, 1–19.
Dishman, R. K., Berthoud, H. R., Booth, F. W. et al (2006) Neurobiology of exercise. Obesity, 14, 345–356.
Eichner, J. E., Dunn, S. T., Perveen, G., Thompson, D. M., Stewart K. E. et al (2002). Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol, 155, 487–495.
Elias, M. F., Sullivan, L. M., Elias, P. K., D’Agostino, R. B., Wolf, P. A. et al (2007). Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension, 49, 439–445.
Elias, M. F., Sullivan, L. M., D’Agostino, R. B., Elias, P. K., Jacques, P. F. et al (2005). Homocysteine and cognitive performance in the Framingham Offspring Study: age is important. Am J Epidemiol 162, 644–653.
Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A. et al (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278, 1349–1356.
Gillette, G. S., Abellan, V. K. G., Andrieu, S., Barberger, G. P., Berr, C. et al (2007). IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging, 11, 132–152.
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B. et al (2007). Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry, 48, 57–61.
Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A., and Kuller, L. (1999). The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA, 282, 40–46.
Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N. et al (2003) Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950.
Kirschbaum, C., Wolf, O. T., May, M., Wippich, W., and Helhammer, D. H. (1996). Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci, 58, 1475–83.
Kuo, H. K., Jones, R. N., Milberg, W. P., Tennstedt, S., Talbot, L. et al (2005). Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc, 53, 1154–61.
Kurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T. et al (2005). Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol, 16, 2127–2133.
Lautenschlager, N. T., Cox, K. L., Flicker, L., Foster, J. K., van Bockxmeer, F. M. et al (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer’s disease: a randomized trial. JAMA, 309. 1027–1037.
Lee, H. B., Kasper, J. D., Shore, A. D., Yokley, J. L., Black, B. S. et al (2006). Level of cognitive impairment predicts mortality in high-risk community samples: The Memory and Medical Care Study. J Neuropsychiatry Clin Neurosci, 18, 543–545.
Lezak, M., Howieson, D. B., and Loring, D. W. (2004). Neuropsychological Assessment, 4th Ed. New York: Oxford University Press.
Lupien, S. J., Fiocco, A., Wan, N., Maheu, F., Lord, C. et al (2005). Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology, 30, 225–242.
McEwen, B. S. (2002). Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging, 23, 921–939.
McSweeney, A. J., and Labuhn, K. T. (1996). The relationship of neuropsychological functioning to health related quality of life in systemic medical disease: the example of chronic pulmonary artery disease. In I. Grant & K. M. Adams (Eds.), Neuropsychological Assessment of Neuropsychiatric Disorders (pp. 3–30). New York: Oxford University Press.
Mead, G. E., and Keir, S. (2001). Association between cognitive impairment and atrial fibrillation: a systematic review. J Stroke Cerebrovasc Dis, 10, 35–43.
Mitrushina, M., Boone, K. B., Razani, J., and D'Elia, L. F. (2005). Handbook of Normative Data for Neuropsychological Assessment, 2nd Ed. New York: Oxford.
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Wilson, R. S. (2004) Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology, 62, 1573–1579.
Morrow, L. A., Muldoon, S. B., and Sandstrom, D. J. (2001). Neuropsychological sequelae associated with occupational and environmental exposure to chemicals. In R. E. Tarter, M. A. Butters, & S. R. Beers (Eds.), Medical neuropsychology (2nd ed.). New York: Plenum Press.
Muldoon, M. F., Flory, J. D., and Ryan, C. M. (2001). Serum cholesterol, the brain and cognition. In, S. R. Waldstein & M. F. Elias (Eds.) Neuropsychology of Cardiovascular Disease (pp. 37–59). Mahwah, NJ: Erlbaum.
Murray, M. D., Lane, K. A., Gao, S., Evans, R. M., Unverzagt, F. W. et al (2002). Preservation of cognitive function with anithypertensive medications. Arch Intern Med, 162, 2090–2096.
O’Brien, J. T. (2006). Vascular cognitive impairment. Am J Geriatr Psychiatry, 14, 724–733.
O’Shaughnessy, J. A. (2002). Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy, Clin Breast Cancer, 3, S116–S120.
Oscar-Berman. M., and Marinkovic, K. (2007). Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev, 17, 239–257.
Phillips, N. A. (2001). Thinking on your feet: A neuropsychological review of peripheral vascular disease. In S. R. Waldstein & M. F. Elias (Eds.), Neuropsychology of cardiovascular Disease. Florence, KY: Erlbaum.
Royter, V., Bornstein, N. M., and Russell, D. (2005). Coronary artery bypass grafting (CABG) and cognitive decline: a review. J Neurol Sci, 230, 65–67.
Sabia, S., Nabi, H., Kivimaki, M., Shipley, M. J., Marmot, M. G. et al (2009). Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. Am J Epidemiol, 170, 428–437.
Sapolsky, R. M. (1999). Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol, 34, 721–32.
Sherwin, B. B. (2003). Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci, 20, 385–393.
Sherwin, B. B. (2006). Estrogen and cognitive aging in women. Neuroscience, 138, 1021–1026.
Smith, J. W., Evans, A. T., Costall, B., and Smythe, J. W. (2002). Thyroid hormones, brain function, and cognition: a brief review. Neurosci Biobehav Rev, 26, 45–60.
Solberg Nes, L., Roach, A. R., and Segerstrom, S. C. (2009). Executive functions, self-regulation, and chronic pain: a review. Ann Behav Med, 37, 173–182.
Strauss, E., Sherman, E. M. S., and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd Ed. Oxford: Oxford University Press.
Stilley, C. S., Sereika, S., Muldoon, M. F., Ryan, C. M., and Dunbar-Jacob, J. (2004). Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med, 27, 117–124.
Stolk, R. P., Breteler, M. M., Ott, A., Pols, H. A., Lamberts, S. W. et al (1997). Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care, 20, 792–795.
Swan, G. E., and Lessov-Schlaggar, C. N. (2007). The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev,17, 259–273.
Szwast, S. J., Hendrie, H. C., Lane, K. A., Gao, S., Taylor, S. E. et al (2007). Association of statin use with cognitive decline in elderly African Americans. Neurology, 69, 1873–1880.
Tarter, R. E., Butters, M. A., and Beers, S. R. (Eds). (2001). Medical Neuropsychology, 2nd Ed. New York: Plenum Press.
Taylor, V. H., and MacQueen, G. M. (2007). Cognitive dysfunction associated with metabolic syndrome. Obes Rev, 8, 409–418.
Thyrum Towner, E., and Blumenthal, J. A. (1995). The effects of hypertension on neurobehavioral functioning. In J. E. Dimsdale & A. Baum (Eds.) Quality of Life in Behavioral Medicine Research (pp. 161–170). Florence, KY: Erlbaum.
Tombaugh, T. N., and McIntyre, N. J. (1992). The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc, 40, 22–935.
Tozzi, V., Balestra, P., Galgani, S., Murri, R., Bellagamba, R. et al (2003). Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses, 19, 643–52.
Vingerhoets, G., Van Nooten, G., and Jannes, C. (1997). Neuropsychological impairment in candidates for cardiac surgery. J Int Neuropsychol Soc, 3, 480–484.
Vogels, R. L., Scheltens, P., Schroeder-Tanka, J. M., and Weinstein, H. C. (2007). Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail, 9, 440–449.
Waldstein, S. R. (2000). Health effects on cognitive aging. In P. C. Stern & L. L. Carstensen (Eds.), The Aging Mind: Opportunities in Cognitive Research (pp. 189–217). Committee on Future Directions for Cognitive Research on Aging. Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
Waldstein, S. R., and Elias, M. F. (2001). Neuropsychology of Cardiovascular Disease. Mahwah, NJ: Lawrence Erlbaum Associates.
Waldstein, S. R., and Katzel LI. (2001) Hypertension and cognitive function. In S. R. Waldstein & M. F. Elias (Eds.) Neuropsychology of Cardiovascular Disease (pp. 15–36). Mahwah, NJ: Erlbaum.
Waldstein, S. R., Katzel, L. I. (2005). Stress-induced blood pressure reactivity and cognitive function. Neurology, 64, 1750–1755.
Waldstein, S. R. Rice, S. C., Hosey, M. M., Seliger, S. L., and Katzel, L. I. (in press). Cardiovascular disease and neurocognitive function. In C. Armstrong & L. A. Morrow (Eds.), Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience. New York: Springer.
Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A. et al (2008). Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension, 51, 99–104.
Waldstein, S. R., Tankard, C. F., Maier, K. J., Pelletier, J. R., Snow, J. et al (2003). Peripheral arterial disease and cognitive function. Psychosom. Med, 65, 757–763.
Wendell, C. R., Zonderman, A. B., Metter, E. J., Najjar, S. S., and Waldstein, S. R. (2009). Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke, 40, 3180–3185.
Williams, P. G., and Thayer, J. F. (2009). Executive functioning and health: introduction to the special series. Ann Behav Med, 37, 101–105.
Woods, S. P., Moran, L. M., Carey, C. L., Dawson, M. S., Iudicello, J. E. et al (2008). Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol, 23, 257–270.
Yaffe, K., Lindquist, K., Penninx, B. W. et al (2003). Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology, 61, 76–80.
Zhang, L. J., Yang, G., Yin, J., Liu, Y., Qi, J. (2007). Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol, 48, 577–587.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Waldstein, S.R., Wendell, C.R., Hosey, M.M. (2010). Applications of Neurocognitive Assessment in Behavioral Medicine. In: Steptoe, A. (eds) Handbook of Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09488-5_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-09488-5_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09487-8
Online ISBN: 978-0-387-09488-5
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)